What Is Tavapadon? Understanding This New Approach for Managing Parkinson’s Motor Symptoms

provides a balanced signal rather than full-on stimulation.

Research from the TEMPO clinical trial program (including TEMPO-1, TEMPO-2, and TEMPO-3) explored this mechanism in both early and more advanced Parkinson’s. Studies showed improvements in motor function scores and daily “on” time when tavapadon was used alone or added to levodopa. One notable finding was an increase of about an extra hour of good symptom control per day in some participants using it alongside levodopa, with many side effects described as mild to moderate.

But that is not the full story